sean pittock, ean 2020 – phase 3 prevent study insights in neuromyelitis optica spectrum disorder
Published 4 years ago • 599 plays • Length 8:00Download video MP4
Download video MP3
Similar videos
-
6:43
sean pittock, ectrims 2022: phase 3 champion-nmosd trial results – ravulizumab for aqp4-igg nmosd
-
3:19
aan16 takeaways: sean pittock, m.d.
-
1:04:48
considering the complete picture in neuromyelitis optica spectrum disorder
-
3:51
neuromyelitis optica spectrum disorder: management essentials for ms clinics
-
3:28
many clinical trials underway for treating neuromyelitis optica
-
12:41
having a brain relapse how i overcame it | my nmo story
-
12:14
how i was diagnose with a rare autoimmune disease, nmo (devic's disease)
-
4:50
i am still the avery of the past | avery’s nmosd story
-
5:42
neuromyelitis optica (nmo) overview -- mayo clinic
-
4:09
neuromyelitis optica (nmo) research -- mayo clinic
-
36:52
autoimmune encephalitis: immunopathogenic mechanisms, ... - dr. sean pittock | building bridges 2021
-
2:45
potential for preventing nmosd, improving access to panel testing
-
36:52
dr. sean pittock
-
![aqp4-igg facs assay: finding nemo [hot topic]](https://i.ytimg.com/vi/noDtkXwB-6o/mqdefault.jpg)
21:35
aqp4-igg facs assay: finding nemo [hot topic]
-
21:23
2022 pre-rnds | neuromyelitis optica spectrum disorder (nmosd)
-
0:51
meet neurointensivist nils petersen, md/phd, msc
-
5:49
new method for nmo testing at mayo clinic
-
1:30
key research questions in seronegative nmosd
-
48:53
latest developments in neuromyelitis optica spectrum disorder
-
18:19
discussion of neuromyelitis optica spectrum disorder (nmosd) and transverse myelitis (tm)